Literature DB >> 6491299

Red cell-labelled monoclonal antibodies for assay of human chorionic gonadotropin and luteinising hormone by reverse passive haemagglutination.

K Siddle, T Gard, D Thomas, M P Cranage, R R Coombs.   

Abstract

The assay of human chorionic gonadotropin and luteinising hormone by reverse passive haemagglutination reaction, using monoclonal antibodies coupled to red cells, is described. Quantitation is achieved by end-point determination for serial dilutions of standard or sample, the haemagglutination reaction being observed after settling under gravity for 90 min. Red cell-labelled antibodies were stabilised with glutaraldehyde without loss of sensitivity and allowing long term storage. Various antibody combinations were assessed, and the best combination under optimum conditions gave a positive haemagglutination reaction down to 0.2 ng/ml with HCG.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491299     DOI: 10.1016/0022-1759(84)90042-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.

Authors:  R Hoermann; P M Schumm-Draeger; K Rehbach; K Mann
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors.

Authors:  R Hoermann; G Spoettl; M Grossmann; B Saller; K Mann
Journal:  Clin Investig       Date:  1993-11

3.  Red-cell IgM-antibody capture assay for the detection of Mycoplasma pneumoniae-specific IgM.

Authors:  R R Coombs; G Easter; P Matejtschuk; T G Wreghitt
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.